Skip to main content
Premium Trial:

Request an Annual Quote

Farcast Biosciences: Maneesh Arora

Maneesh Arora has joined Boston-based diagnostics firm Farcast Biosciences as president and CEO. Arora previously served as COO and a member of the board of directors of Exact Sciences. He also previously was CFO of Third Wave Technologies, which was acquired in 2008 by Hologic for $582 million. Farcast, formerly called Mitra Biotech, has developed an ex vivo platform for evaluating tumor response to drug treatments.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.